Scivision Biotech (TPE:1786) Total Operating Expense: NT$448.5 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1786 Scivision Biotech Inc TPE:1786
80 GF Score
Price NT$53.80
GF Value NT$115.46
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Scivision Biotech Total Operating Expense?

Scivision Biotech TPE:1786 -3.93% 80 Total Operating Expense is NT$448.5 Mil as of Dec. 2025. GuruFocus rates TPE:1786 with a GF Score™ of 80/100 and a GF Value™ of NT$115.46 (Possible Value Trap). The stock has 4 warning signs investors should review.

Scivision Biotech's Total Operating Expense for the three months ended in Dec. 2025 was NT$139.4 Mil. Scivision Biotech's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$448.5 Mil.

Scivision Biotech Total Operating Expense Related Terms

Scivision Biotech Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Scivision Biotech's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scivision Biotech Total Operating Expense Chart

Scivision Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 219.89 237.26 312.86 407.57 448.47

Scivision Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 129.28 81.57 119.84 107.65 139.42
TPE:1786
80GF Score
Scivision Biotech Inc TPE:1786
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scivision Biotech Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$448.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of NT$448.5 Mil mean?
Scivision Biotech (TPE:1786) has a Total Operating Expense of NT$448.5 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Scivision Biotech and its competitors.
Is Scivision Biotech's Total Operating Expense too high?
Scivision Biotech's current Total Operating Expense is NT$448.5 Mil. Overall, Scivision Biotech has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Scivision Biotech's Total Operating Expense compare to ISRG and BDX?
Scivision Biotech's Total Operating Expense of NT$448.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Scivision Biotech and its competitors. Scivision Biotech's current Total Operating Expense is NT$448.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scivision Biotech stock overvalued right now?
Based on GuruFocus' analysis, Scivision Biotech (TPE:1786) is currently considered Possible Value Trap. The stock's GF Value™ is NT$115.46, compared to a current price of NT$53.80 — trading 53.4% below its estimated fair value. The current Total Operating Expense is NT$448.5 Mil. Scivision Biotech's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Scivision Biotech (TPE:1786), the current Total Operating Expense is NT$448.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scivision Biotech (TPE:1786) Overvalued in 2026?

Based on GuruFocus' analysis, Scivision Biotech stock appears to be undervalued. The current stock price of NT$53.80 is trading 53.4% below its estimated GF Value™ of NT$115.46. GuruFocus considers Scivision Biotech to be Possible Value Trap.

Key valuation signals for TPE:1786:

  • Total Operating Expense: NT$448.5 Mil
  • GF Value™: NT$115.46 vs. price of NT$53.80 (53.4% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the TPE:1786 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scivision Biotech Business Description

Address No. 1, South 1st Road, Qianzhen District, Kaohsiung, TWN, 806
Scivision Biotech Inc is engaged in the manufacturing and distribution of hyaluronic acid medical supplies in Taiwan. It offers medical devices, including absorbable adhesion barriers, dermal implants, synovial fluid supplements, and intravesical instillation.
80GF Score

Get the complete analysis for TPE:1786

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$53.80
Price
NT$115.46
GF Value